{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-113085","form_type":"8-K","ticker":"QNRX","cik":"0001671502","company_name":"Quoin Pharmaceuticals, Ltd.","filed_at":"2024-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.175327+00:00","generated_at":"2026-05-30T07:28:52.196283+00:00","sec_items":["3.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Quoin Pharma gets Nasdaq bid-price extension to April 28, 2025","bullets":["Nasdaq granted additional 180-day grace period until April 28, 2025 to regain $1.00 minimum bid price compliance.","Company met all other Nasdaq Capital Market initial listing requirements; may effect reverse split if needed.","If compliance not achieved by April 28, 2025, securities will be delisted, subject to appeal."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-113085","json":"https://secwatch.observer/filing/0001104659-24-113085.json","markdown":"https://secwatch.observer/filing/0001104659-24-113085.md","text":"https://secwatch.observer/filing/0001104659-24-113085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924113085/0001104659-24-113085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1671502/000110465924113085/tm2427194d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T07:28:52.196283+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}